Monoclonal Antibodies in Neurology: Current State and Future Development

Monoclonal antibodies are one of the fastest growing areas of specific therapy for cancer, infectious, autoimmune, and demyelinating diseases. The main targets of monoclonal antibodies in autoimmune and demyelinating diseases are T and B lymphocytes, cytokines, complement, and adhesion molecules. In...

Full description

Saved in:

Bibliographic Details
Published in:	Human physiology Vol. 48; no. 8; pp. 932 - 937
Main Author:	Zakharova, M. N.
Format:	Journal Article
Language:	English
Published:	Moscow Pleiades Publishing 01.12.2022 Springer Nature B.V
Subjects:	Alzheimer's disease Autoimmune diseases Biomedical and Life Sciences Biomedicine CD19 antigen CD20 antigen Demyelinating diseases Demyelination Human Physiology Life Sciences Lymphocytes B Monoclonal antibodies Multiple sclerosis Nanobodies Neurodegenerative diseases Neuromyelitis Parenchyma β-Amyloid nanobodies Alzheimer’s disease demyelinating diseases multiple sclerosis neuromyelitis optica monoclonal antibodies
ISSN:	0362-1197, 1608-3164
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!